21-46112526-C-T

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001849.4(COL6A2):​c.663C>T​(p.Pro221Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0851 in 1,607,688 control chromosomes in the GnomAD database, including 6,105 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.097 ( 716 hom., cov: 31)
Exomes 𝑓: 0.084 ( 5389 hom. )

Consequence

COL6A2
NM_001849.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: -4.81
Variant links:
Genes affected
COL6A2 (HGNC:2212): (collagen type VI alpha 2 chain) This gene encodes one of the three alpha chains of type VI collagen, a beaded filament collagen found in most connective tissues. The product of this gene contains several domains similar to von Willebrand Factor type A domains. These domains have been shown to bind extracellular matrix proteins, an interaction that explains the importance of this collagen in organizing matrix components. Mutations in this gene are associated with Bethlem myopathy and Ullrich scleroatonic muscular dystrophy. Three transcript variants have been identified for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.61).
BP6
Variant 21-46112526-C-T is Benign according to our data. Variant chr21-46112526-C-T is described in ClinVar as [Benign]. Clinvar id is 93955.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr21-46112526-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-4.81 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.123 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL6A2NM_001849.4 linkc.663C>T p.Pro221Pro synonymous_variant Exon 3 of 28 ENST00000300527.9 NP_001840.3 P12110-1A0A384MDP3
COL6A2NM_058174.3 linkc.663C>T p.Pro221Pro synonymous_variant Exon 3 of 28 NP_478054.2 P12110-2
COL6A2NM_058175.3 linkc.663C>T p.Pro221Pro synonymous_variant Exon 3 of 28 NP_478055.2 P12110-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL6A2ENST00000300527.9 linkc.663C>T p.Pro221Pro synonymous_variant Exon 3 of 28 1 NM_001849.4 ENSP00000300527.4 P12110-1

Frequencies

GnomAD3 genomes
AF:
0.0968
AC:
14394
AN:
148678
Hom.:
715
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.126
Gnomad AMI
AF:
0.113
Gnomad AMR
AF:
0.0938
Gnomad ASJ
AF:
0.0816
Gnomad EAS
AF:
0.127
Gnomad SAS
AF:
0.0538
Gnomad FIN
AF:
0.0934
Gnomad MID
AF:
0.0709
Gnomad NFE
AF:
0.0819
Gnomad OTH
AF:
0.105
GnomAD3 exomes
AF:
0.0854
AC:
20844
AN:
244032
Hom.:
967
AF XY:
0.0835
AC XY:
11133
AN XY:
133376
show subpopulations
Gnomad AFR exome
AF:
0.125
Gnomad AMR exome
AF:
0.0755
Gnomad ASJ exome
AF:
0.0776
Gnomad EAS exome
AF:
0.126
Gnomad SAS exome
AF:
0.0610
Gnomad FIN exome
AF:
0.0924
Gnomad NFE exome
AF:
0.0827
Gnomad OTH exome
AF:
0.0810
GnomAD4 exome
AF:
0.0839
AC:
122364
AN:
1458894
Hom.:
5389
Cov.:
35
AF XY:
0.0833
AC XY:
60487
AN XY:
725808
show subpopulations
Gnomad4 AFR exome
AF:
0.127
Gnomad4 AMR exome
AF:
0.0770
Gnomad4 ASJ exome
AF:
0.0796
Gnomad4 EAS exome
AF:
0.102
Gnomad4 SAS exome
AF:
0.0607
Gnomad4 FIN exome
AF:
0.0951
Gnomad4 NFE exome
AF:
0.0835
Gnomad4 OTH exome
AF:
0.0848
GnomAD4 genome
AF:
0.0969
AC:
14419
AN:
148794
Hom.:
716
Cov.:
31
AF XY:
0.0965
AC XY:
7006
AN XY:
72628
show subpopulations
Gnomad4 AFR
AF:
0.126
Gnomad4 AMR
AF:
0.0937
Gnomad4 ASJ
AF:
0.0816
Gnomad4 EAS
AF:
0.127
Gnomad4 SAS
AF:
0.0532
Gnomad4 FIN
AF:
0.0934
Gnomad4 NFE
AF:
0.0819
Gnomad4 OTH
AF:
0.105
Alfa
AF:
0.0852
Hom.:
319
Bravo
AF:
0.0982
Asia WGS
AF:
0.0840
AC:
292
AN:
3478
EpiCase
AF:
0.0796
EpiControl
AF:
0.0790

ClinVar

Significance: Benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:7
Feb 09, 2016
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Jul 17, 2012
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Aug 15, 2013
Genetic Services Laboratory, University of Chicago
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Jan 25, 2016
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Nov 06, 2017
Athena Diagnostics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Myosclerosis Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Bethlem myopathy 1A Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Collagen 6-related myopathy Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.61
CADD
Benign
1.9
DANN
Benign
0.86

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs59531343; hg19: chr21-47532440; COSMIC: COSV56006039; COSMIC: COSV56006039; API